138 Works
Additional file 2 of VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer—a randomized phase III trial
Philipp Reinhardt, Roland Giger, Eberhard Seifert, Mohamed Shelan, Elena Riggenbach, Dario Terribilini, Andreas Joosten, Daniel H. Schanne, Daniel M. Aebersold, Peter Manser, Matthias S. Dettmer, Christian Simon, Esat M. Ozsahin, Raphaël Moeckli, Andreas Limacher, Francesca Caparrotti, Deepa Nair, Jean Bourhis, Martina A. Broglie, Abrahim Al-Mamgani & Olgun Elicin
Additional file 2. SPIRIT checklist
VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer—a randomized phase III trial
Philipp Reinhardt, Roland Giger, Eberhard Seifert, Mohamed Shelan, Elena Riggenbach, Dario Terribilini, Andreas Joosten, Daniel H. Schanne, Daniel M. Aebersold, Peter Manser, Matthias S. Dettmer, Christian Simon, Esat M. Ozsahin, Raphaël Moeckli, Andreas Limacher, Francesca Caparrotti, Deepa Nair, Jean Bourhis, Martina A. Broglie, Abrahim Al-Mamgani & Olgun Elicin
Abstract Background Surgery and radiotherapy are well-established standards of care for unilateral stage 0 and I early-stage glottic cancer (ESGC). Based on comparative studies and meta-analyses, functional and oncological outcomes after both treatment modalities are similar. Historically, radiotherapy (RT) has been performed by irradiation of the whole larynx. However, only the involved vocal cord is being treated with recently introduced hypofractionated concepts that result in 8 to 10-fold smaller target volumes. Retrospective data argues for...
Additional file 3 of Reproducibility of lung cancer radiomics features extracted from data-driven respiratory gating and free-breathing flow imaging in [18F]-FDG PET/CT
Daphné Faist, Mario Jreige, Valentin Oreiller, Marie Nicod Lalonde, Niklaus Schaefer, Adrien Depeursinge & John O. Prior
Additional file 3. Differences and concordance among free-breathing and data-driven gating PET/CT for all radiomics features calculated separately based on pulmonary lesions localisation. The relative difference in percentage (DIFF%) and the concordance bias coefficient (Cb) are presented for each of the 141 radiomics features derived separately on each group “superior” and “inferior” depending on their anatomical localisation: lesions in the superior lobes versus the inferior regions. Non-reproducible features are marked with a star.
sj-pdf-3-pal-10.1177_08258597221138674 - Supplemental material for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review
Martyna Tomczyk, Cécile Jaques & Ralf J. Jox
Supplemental material, sj-pdf-3-pal-10.1177_08258597221138674 for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review by Martyna Tomczyk, Cécile Jaques and Ralf J. Jox in Journal of Palliative Care
sj-pdf-4-pal-10.1177_08258597221138674 - Supplemental material for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review
Martyna Tomczyk, Cécile Jaques & Ralf J. Jox
Supplemental material, sj-pdf-4-pal-10.1177_08258597221138674 for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review by Martyna Tomczyk, Cécile Jaques and Ralf J. Jox in Journal of Palliative Care
sj-pdf-5-pal-10.1177_08258597221138674 - Supplemental material for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review
Martyna Tomczyk, Cécile Jaques & Ralf J. Jox
Supplemental material, sj-pdf-5-pal-10.1177_08258597221138674 for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review by Martyna Tomczyk, Cécile Jaques and Ralf J. Jox in Journal of Palliative Care
sj-pdf-5-pal-10.1177_08258597221138674 - Supplemental material for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review
Martyna Tomczyk, Cécile Jaques & Ralf J. Jox
Supplemental material, sj-pdf-5-pal-10.1177_08258597221138674 for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review by Martyna Tomczyk, Cécile Jaques and Ralf J. Jox in Journal of Palliative Care
sj-pdf-15-pal-10.1177_08258597221138674 - Supplemental material for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review
Martyna Tomczyk, Cécile Jaques & Ralf J. Jox
Supplemental material, sj-pdf-15-pal-10.1177_08258597221138674 for Clinical Practice Guidelines on Palliative Sedation Around the World: A Systematic Review by Martyna Tomczyk, Cécile Jaques and Ralf J. Jox in Journal of Palliative Care
Drinking during low-risk labor: monocentric randomized clinical trial on patients’ satisfaction, and maternal and neonatal outcomes
Justine Nadal, Fabrice Pierre, Anna Fernandez, Emilie Boussac, Thibaut Loupec & David Desseauve
This study aimed to assess satisfaction of patients affected by various fluid regimes during uncomplicated labor; to identify factors possibly associated with the level of satisfaction; to compare obstetrical and neonatal outcomes between the intervention groups. Between October and December 2014, 40 women were included in the study set at the Poitiers University Hospital, France. Women were randomly allocated to two study arms: 20 to strict and 20 to liberal fluid regime group. Women’s satisfaction...
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes
Vasiliki Papadopoulou, Jacqueline Schoumans, Valentin Basset, Françoise Solly, Jérôme Pasquier, Sabine Blum & Olivier Spertini
IDH1/2 mutations, intervening in epigenetic procedures, are frequently encountered in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Knowledge of the genetics, immunophenotypes, and mutational kinetics of IDH1/2-mutated AML can contribute to the understanding of AML clonal architecture and inform therapeutics and monitoring. We retrospectively analyzed 50 IDH1/2-mutated AML/MDS-EB cases of our institution, to identify recurrent co-mutations, immunophenotypes, patterns of co-variance of IDH1/2 allele burdens with those of recurrent co-mutations, frequency of persistent IDH1/2 mutation...
Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata
Sanne Schrevens, Eric Durandau, Van Du T. Tran & Dominique Sanglard
Candida species are the most commonly isolated opportunistic fungal pathogens in humans. Candida albicans causes most of the diagnosed infections, closely followed by Candida glabrata. C. albicans is well studied, and many genes have been shown to be important for infection and colonization of the host. It is however less clear how C. glabrata infects the host. With the help of fungal RNA enrichment, we here investigated for the first time the transcriptomic profile of...
Additional file 1 of An algorithm based on the postoperative decrease of albumin (ΔAlb) to anticipate complications after liver surgery
Ismail Labgaa, Luis Cano, Orsalia Mangana, Gaëtan-Romain Joliat, Emmanuel Melloul, Nermin Halkic, Markus Schäfer, Eric Vibert, Nicolas Demartines, Nicolas Golse & Martin Hübner
Additional file 1: Supplementary Table 1. Characteristics of the final cohort were compared with the excluded patients.
Additional file 1 of Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents (the TECTO trial): a statistical analysis plan for the randomised clinical trial
Markus Harboe Olsen, Julie Hagstrøm, Nicole Nadine Lønfeldt, Camilla Uhre, Valdemar Uhre, Linea Pretzmann, Sofie Heidenheim Christensen, Christine Thoustrup, Nicoline Løcke Jepsen Korsbjerg, Anna-Rosa Cecilie Mora-Jensen, Melanie Ritter, Janus Engstrøm, Jane Lindschou, Hartwig Roman Siebner, Frank Verhulst, Pia Jeppesen, Jens Richardt Møllegaard Jepsen, Signe Vangkilde, Per Hove Thomsen, Katja Hybel, Line Katrine Harder Clemmesen, Christian Gluud, Kerstin Jessica Plessen, Anne Katrine Pagsberg & Janus Christian Jakobsen
Additional file 1: Table 1. Participant characteristics. Figure 1. CONSORT flow diagram. Figure 2. Psychopathology and family burden. Figure 3. Response status at 16 weeks. Figure 4. Negative effects questionnaire. Supplemental Table 1. Detailed comorbidities. Supplemental Table 2. Psychopathology and family burden. Supplemental Table 3. Kidscreen-52. Supplemental Timeline. Supplemental Assumptions.
Affiliations
-
University Hospital of Lausanne138
-
University of Lausanne98
-
HES-SO Valais-Wallis20
-
Swiss Institute of Bioinformatics19
-
École Polytechnique Fédérale de Lausanne15
-
German Cancer Research Center13
-
University Hospital of Geneva10
-
University Hospital of Zurich9
-
University Hospital of Bern9
-
Inserm8